US4920214A
(en)
*
|
1986-04-16 |
1990-04-24 |
American Maize-Products Company |
Process for producing modified cyclodextrins
|
JPH0819004B2
(ja)
*
|
1986-12-26 |
1996-02-28 |
日清製粉株式会社 |
徐放性医薬製剤
|
IT1203968B
(it)
*
|
1987-04-24 |
1989-02-23 |
Bononi Ricerca |
Complessi di b-ciclodestrina ad attivita' antimicotica
|
NZ224497A
(en)
*
|
1987-05-18 |
1990-04-26 |
Janssen Pharmaceutica Nv |
Pharmaceutical composition comprising flunarizine
|
JP2577049B2
(ja)
*
|
1987-06-04 |
1997-01-29 |
三共株式会社 |
シクロスポリン製剤
|
NZ225045A
(en)
*
|
1987-07-01 |
1990-06-26 |
Janssen Pharmaceutica Nv |
Antiviral pharmaceutical compositions containing cyclodextrin and an antiviral agent
|
ZA884592B
(en)
*
|
1987-08-31 |
1989-03-29 |
Warner Lambert Co |
Cyclodextrin complexes of bis-biguanido hexane compounds
|
US4877774A
(en)
*
|
1987-09-09 |
1989-10-31 |
The United States Of America As Represented By The Department Of Health And Human Services |
Administration of steroid hormones
|
US5256652A
(en)
*
|
1987-11-12 |
1993-10-26 |
Pharmedic Co. |
Topical compositions and methods for treatment of male impotence
|
US5221695A
(en)
*
|
1987-12-22 |
1993-06-22 |
Glaxo Group Limited |
Aqueous formulation containing a piperidinylcyclopentylheptenoic acid derivative and beta-cyclodextrin
|
HU204700B
(en)
*
|
1987-12-22 |
1992-02-28 |
Glaxo Group Ltd |
Process for producing aqueous compositions comprising piperidinyl cyclopentylheptenoic acid derivatives
|
US5017566A
(en)
*
|
1987-12-30 |
1991-05-21 |
University Of Florida |
Redox systems for brain-targeted drug delivery
|
US5002935A
(en)
*
|
1987-12-30 |
1991-03-26 |
University Of Florida |
Improvements in redox systems for brain-targeted drug delivery
|
ES2037385T3
(es)
*
|
1988-01-14 |
1993-06-16 |
Akzo N.V. |
Un procedimiento de manufactura de una preparacion farmaceutica para administracion local.
|
AU626538B2
(en)
*
|
1988-01-19 |
1992-08-06 |
Moses Judah Folkman |
Growth inhibiting agent and the use thereof
|
US5760015A
(en)
*
|
1988-01-19 |
1998-06-02 |
The Trustees Of The University Of Pennsylvania |
Cyclodextrin compounds and methods of making and use thereof
|
US5637575A
(en)
*
|
1988-01-19 |
1997-06-10 |
The Trustees Of The University Of Pennsylvania |
Methods of inhibiting restenosis
|
US5019562A
(en)
*
|
1988-01-19 |
1991-05-28 |
The Trustees Of The University Of Pennsylvania/Childrens Hospital Corporation |
Growth inhibiting agent and the use thereof
|
WO1989006536A1
(en)
*
|
1988-01-19 |
1989-07-27 |
Moses Judah Folkman |
Growth inhibiting agent and the use thereof
|
US5658894A
(en)
*
|
1989-04-23 |
1997-08-19 |
The Trustees Of The University Of Pennsylvania |
Compositions for inhibiting restenosis
|
DE3809808A1
(de)
*
|
1988-03-23 |
1989-10-05 |
Hexal Pharma Gmbh & Co Kg |
Feste, insbesondere festorale und rektale, etofenamat enthaltende arzneimittel
|
US5236944A
(en)
*
|
1988-03-28 |
1993-08-17 |
Janssen Pharmaceutica N.V. |
Compounds, compositions and anti-neoplastic methods
|
DE3815902A1
(de)
*
|
1988-05-10 |
1989-11-23 |
Schwarz Pharma Gmbh |
Einschlussverbindungen des 1-(4-(2-(5-chloro-2-methoxybenzamido)ethyl) -phenylsulfonyl)-3-cyclohexylharnstoffs mit (alpha)-,ss-,(gamma)-cyclodextrinen, jeweils diese enthaltendes pharmazeutisches praeparat und verfahren zu deren herstellung
|
GB8813682D0
(en)
*
|
1988-06-09 |
1988-07-13 |
Reckitt & Colmann Prod Ltd |
Pharmaceutical compositions
|
NL8801670A
(nl)
|
1988-07-01 |
1990-02-01 |
Walter Adrianus Josephus Johan |
Farmaceutisch preparaat.
|
EP0381747A4
(en)
*
|
1988-08-15 |
1991-09-11 |
American Maize-Products Company |
Water soluble branched beta cyclodextrin steroid complex
|
US5229370A
(en)
*
|
1988-08-15 |
1993-07-20 |
Ammeraal Robert N |
Water soluble branched beta cyclodextrin steroid complex
|
MY106598A
(en)
*
|
1988-08-31 |
1995-06-30 |
Australian Commercial Res & Development Ltd |
Compositions and methods for drug delivery and chromatography.
|
US5997856A
(en)
*
|
1988-10-05 |
1999-12-07 |
Chiron Corporation |
Method and compositions for solubilization and stabilization of polypeptides, especially proteins
|
AU616571B2
(en)
*
|
1988-10-28 |
1991-10-31 |
Shiseido Company Ltd. |
Cosmetic composition containing inclusion product with hydroxyalkylated cyclodextrin
|
JP2929108B2
(ja)
*
|
1988-10-28 |
1999-08-03 |
株式会社資生堂 |
化粧料および粉末化粧料
|
IT1227626B
(it)
*
|
1988-11-28 |
1991-04-23 |
Vectorpharma Int |
Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
|
US5441944A
(en)
*
|
1989-04-23 |
1995-08-15 |
The Trustees Of The University Of Pennsylvania |
Substituted cyclodextrin sulfates and their uses as growth modulating agents
|
GB8910069D0
(en)
*
|
1989-05-03 |
1989-06-21 |
Janssen Pharmaceutica Nv |
Method of topically treating acne vulgaris
|
JPH0737390B2
(ja)
*
|
1989-08-29 |
1995-04-26 |
久光製薬株式会社 |
軟膏組成物
|
EP0491812A4
(en)
*
|
1989-09-14 |
1992-11-04 |
Australian Commercial Research & Development Limited |
Drug delivery compositions
|
US5053240A
(en)
*
|
1989-10-24 |
1991-10-01 |
Kalamazoo Holdings, Inc. |
Norbixin adducts with water-soluble or water-dispersible proteins or branched-chain or cyclic polysaccharides
|
GB9001987D0
(en)
*
|
1990-01-29 |
1990-03-28 |
Janssen Pharmaceutica Nv |
Improved cyclodextrin based erythropietin formulation
|
WO1991013100A1
(en)
*
|
1990-03-02 |
1991-09-05 |
Australian Commercial Research & Development Limited |
Cyclodextrin compositions and methods for pharmaceutical and industrial applications
|
FR2660309B1
(fr)
*
|
1990-03-27 |
1992-07-17 |
Roussel Uclaf |
Nouveaux complexes de l'acide tiaprofenique ou de ses esters insolubles ou partiellement solubles avec les cyclodextrines ou leurs derives.
|
JP2867162B2
(ja)
*
|
1990-03-31 |
1999-03-08 |
株式会社資生堂 |
ピールオフ型パック化粧料
|
US5124154A
(en)
*
|
1990-06-12 |
1992-06-23 |
Insite Vision Incorporated |
Aminosteroids for ophthalmic use
|
US5120720A
(en)
*
|
1990-09-20 |
1992-06-09 |
The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services |
Preparation of lipophile:hydroxypropylcyclodextrin complexes by a method using co-solubilizers
|
LU87843A1
(fr)
*
|
1990-11-15 |
1992-08-25 |
Cird Galderma |
Gel aqueux a base d'acide retinoique et d'hydroxypropyl-beta-cyclodextrine et son utilisation en medecine humaine et en cosmetique
|
JPH04351603A
(ja)
*
|
1991-05-29 |
1992-12-07 |
Toppan Printing Co Ltd |
β−シクロデキストリン誘導体
|
ATE196426T1
(de)
*
|
1991-06-21 |
2000-10-15 |
Takeda Chemical Industries Ltd |
Zyklodextrin-zusammensetzung enthaltend fumagillol-derivate
|
US5446030A
(en)
*
|
1991-09-19 |
1995-08-29 |
Weisz; Paul B. |
Prevention of hemolysis
|
AU678344B2
(en)
*
|
1991-10-16 |
1997-05-29 |
Schering Corporation |
Lipophilic oligosaccharide antibiotic salt compositions
|
IL103558A0
(en)
|
1991-10-30 |
1993-03-15 |
Schering Corp |
Tri-substituted tetrahydrofuran antifungals
|
US5254541A
(en)
*
|
1991-11-15 |
1993-10-19 |
Merck Frosst Canada, Inc. |
(Quinolin-2-ylmethoxy)indole/cyclodextrin complex
|
DE4207922A1
(de)
*
|
1992-03-13 |
1993-09-23 |
Pharmatech Gmbh |
Wasserloesliche einschlussverbindungen und verfahren zu deren herstellung
|
US5324718A
(en)
*
|
1992-07-14 |
1994-06-28 |
Thorsteinn Loftsson |
Cyclodextrin/drug complexation
|
US5472954A
(en)
*
|
1992-07-14 |
1995-12-05 |
Cyclops H.F. |
Cyclodextrin complexation
|
DE4227569C1
(de)
*
|
1992-08-20 |
1994-06-09 |
Inst Chemo Biosensorik |
Verfahren zum empfindlichen enzymatischen Nachweis von anorganischem Phosphat
|
TW251236B
(xx)
*
|
1992-09-10 |
1995-07-11 |
Ciba Vision Ag |
|
JP2879395B2
(ja)
*
|
1992-10-26 |
1999-04-05 |
富士写真フイルム株式会社 |
ロダシアニン化合物及びシクロデキストリンを含有する抗癌性組成物
|
US5494901A
(en)
*
|
1993-01-05 |
1996-02-27 |
Javitt; Jonathan C. |
Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent
|
DE69427467T2
(de)
*
|
1993-03-05 |
2002-06-06 |
Hexal Ag |
Kristallinische cyclodextrin-einschlusskomplexe von ranitidinhxdrochlorid und verfahren
|
AU6553994A
(en)
*
|
1993-03-31 |
1994-10-24 |
Trustees Of The University Of Pennsylvania, The |
Methods of affecting the growth of living tissue in mammals and compounds and compositions therefor
|
DK94093D0
(da)
*
|
1993-08-17 |
1993-08-17 |
Finn Molke Borgbjerg |
Lokalanaestetisk praeparat
|
PH31594A
(en)
*
|
1993-09-30 |
1998-11-03 |
Janssen Pharmaceutica Nv |
Oral formulations on an antifungal.
|
RU2135176C1
(ru)
*
|
1993-12-14 |
1999-08-27 |
Эли Лилли Энд Компани |
Водорастворенный комплекс включения соединений бензотиофена с водорастворимым циклодекстрином, способ его получения и фармацевтическая композиция
|
US5646131A
(en)
*
|
1994-02-22 |
1997-07-08 |
The Arab Company For Drug Industries And Medical Applicances (Acdima) |
Method for solubilizing drugs using cyclodextrins and carboxylic acids
|
AU1716995A
(en)
*
|
1994-03-18 |
1995-10-09 |
Ciba-Geigy Ag |
Aqueous solution of levocabastine for ophthalmic use
|
DE4414138A1
(de)
*
|
1994-04-22 |
1995-10-26 |
Consortium Elektrochem Ind |
Acylierte gamma-Cyclodextrine
|
JPH10500982A
(ja)
*
|
1994-05-27 |
1998-01-27 |
ファーマーク、ネダーランド、ベスローテン、フェンノートシャップ |
医薬組成物
|
FR2726765B1
(fr)
*
|
1994-11-14 |
1996-12-20 |
Cis Bio Int |
Compositions radiopharmaceutiques comprenant un complexe d'inclusion d'une cyclodextrine et d'un acide gras radiohalogene
|
US5576311A
(en)
*
|
1994-11-30 |
1996-11-19 |
Pharmos Corporation |
Cyclodextrins as suspending agents for pharmaceutical suspensions
|
FR2735136B1
(fr)
*
|
1995-06-08 |
1997-08-14 |
Roquette Freres |
Composition pulverulente d'hydroxypropyl-betacyclodextrine et son procede de preparation.
|
JP2920611B2
(ja)
*
|
1995-12-11 |
1999-07-19 |
株式会社シーエーシー |
皮膚炎の治療外用剤
|
GB9605705D0
(en)
|
1996-03-19 |
1996-05-22 |
Pfizer Ltd |
Therapeutic agents
|
DE69733664T3
(de)
|
1996-04-19 |
2011-04-14 |
Grifols Inc. (n.d. Ges.d.Staates Delaware), Los Angeles |
Verfahren zur INaktivierung von Viren und Lyophilisierung von Blutproteinen
|
SE9601556D0
(sv)
*
|
1996-04-24 |
1996-04-24 |
Astra Ab |
New pharmaceutical formulation of a thrombin inhibitor for parenteral use
|
US5985310A
(en)
*
|
1996-08-09 |
1999-11-16 |
Alcon Laboratories, Inc. |
Preservative systems for pharmaceutical compositions containing cyclodextrins
|
US5942501A
(en)
*
|
1996-08-16 |
1999-08-24 |
Collaborative Laboratories, Inc. |
Cyclodextrin derivative complex
|
EP0838225A3
(en)
*
|
1996-10-25 |
1999-03-24 |
Hiji, Yasutake |
Aqueous local anesthetic solution
|
RU2218153C2
(ru)
*
|
1997-03-26 |
2003-12-10 |
Жансен Фармасетика Н.В. |
Драже, имеющее ядро, покрытое противогрибковым средством и полимером
|
GB9713149D0
(en)
|
1997-06-21 |
1997-08-27 |
Pfizer Ltd |
Pharmaceutical formulations
|
RU2216549C2
(ru)
|
1997-11-07 |
2003-11-20 |
Дайити Фармасьютикал Ко., Лтд. |
Пиперазин-циклодекстриновый комплекс и лекарственное средство, содержащее указанный комплекс
|
PL191181B1
(pl)
|
1997-12-31 |
2006-03-31 |
Choongwae Pharma Corp |
Sposób wytwarzania doustnego preparatu itrakonazolu i doustny preparat itrakonazolu
|
US6683100B2
(en)
|
1999-01-19 |
2004-01-27 |
Novartis Ag |
Organic compounds
|
US6194181B1
(en)
|
1998-02-19 |
2001-02-27 |
Novartis Ag |
Fermentative preparation process for and crystal forms of cytostatics
|
DE19848303A1
(de)
*
|
1998-10-14 |
2000-04-20 |
Schering Ag |
Kombination aus Gestagenen und Zuckern
|
GB9906126D0
(en)
*
|
1999-03-18 |
1999-05-12 |
Knoll Ag |
Pharmaceutical formulations
|
AU5975700A
(en)
*
|
1999-07-02 |
2001-01-22 |
Janssen Pharmaceutica N.V. |
Nasal formulation of an antifungal
|
SE9902988D0
(sv)
*
|
1999-08-24 |
1999-08-24 |
Astra Ab |
Chemical compounds
|
AU2001259306A1
(en)
|
2000-05-02 |
2001-11-12 |
Advanced Medicine, Inc. |
Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin
|
US6468989B1
(en)
*
|
2000-07-13 |
2002-10-22 |
Dow Pharmaceutical Sciences |
Gel compositions containing metronidazole
|
PE20020300A1
(es)
|
2000-08-22 |
2002-05-10 |
Pharmacia Corp |
Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco
|
US7074824B2
(en)
|
2001-07-31 |
2006-07-11 |
Arqule, Inc. |
Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
|
US6962944B2
(en)
|
2001-07-31 |
2005-11-08 |
Arqule, Inc. |
Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
|
US6982256B2
(en)
|
2001-09-07 |
2006-01-03 |
Boehringer Ingelheim Pharma Kg |
Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine in intravenous administration
|
EP1443969A2
(en)
|
2001-10-18 |
2004-08-11 |
Decode Genetics EHF |
Non-inclusion cyclodextrin complexes
|
GB0127677D0
(en)
*
|
2001-11-19 |
2002-01-09 |
Vianex S A |
Inclusion complex
|
US6881726B2
(en)
|
2001-12-24 |
2005-04-19 |
Dow Pharmaceutical Sciences |
Aqueous compositions containing metronidazole
|
CA2477044A1
(en)
|
2002-02-22 |
2003-09-04 |
Pharmacia Corporation |
Ophthalmic formulation with gum system
|
US6951846B2
(en)
*
|
2002-03-07 |
2005-10-04 |
The United States Of America As Represented By The Secretary Of The Army |
Artemisinins with improved stability and bioavailability for therapeutic drug development and application
|
US6818662B2
(en)
|
2002-05-28 |
2004-11-16 |
Taisho Pharmaceutical Co., Ltd. |
Pharmaceutical composition
|
DE10228049A1
(de)
*
|
2002-06-24 |
2004-01-15 |
Merck Patent Gmbh |
Flüssige Zubereitung enthaltend Oligopeptide
|
KR101129816B1
(ko)
|
2003-03-28 |
2012-03-26 |
아레스 트레이딩 에스.아. |
클라드리빈의 경구용 제형
|
JP5412709B2
(ja)
|
2003-03-28 |
2014-02-12 |
アレス トレーディング ソシエテ アノニム |
改良された経口及び経粘膜デリバリーのためのクラドリビン製剤
|
UA81305C2
(en)
|
2003-07-02 |
2007-12-25 |
Ares Trading Sa |
Formulation of cladribine (variants), cladribine-cyclodextrin complex, use of cladribine-cyclodextrin complex, mixture
|
CN1294912C
(zh)
*
|
2004-03-01 |
2007-01-17 |
上海医药工业研究院 |
伊曲康唑盐酸盐组合物及其冻干粉针
|
DE102004011512B4
(de)
|
2004-03-08 |
2022-01-13 |
Boehringer Ingelheim Vetmedica Gmbh |
Pharmazeutische Zubereitung enthaltend Pimobendan
|
US8980894B2
(en)
|
2004-03-25 |
2015-03-17 |
Boehringer Ingelheim Vetmedica Gmbh |
Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
|
EP1579862A1
(en)
|
2004-03-25 |
2005-09-28 |
Boehringer Ingelheim Vetmedica Gmbh |
Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
|
ITMI20041763A1
(it)
*
|
2004-09-16 |
2004-12-16 |
Altergon Sa |
Nuove formulazioni iniettabili contenenti progesterone
|
WO2006137433A1
(ja)
*
|
2005-06-21 |
2006-12-28 |
Wakamoto Pharmaceutical Co., Ltd. |
レボカバスチンを可溶化させた水性薬剤
|
US7744904B1
(en)
*
|
2005-09-26 |
2010-06-29 |
B.B. Scientific L.L.C. |
Stabilization of Clostridium botulinum neurotoxin complex
|
PL2054040T3
(pl)
|
2006-08-16 |
2011-09-30 |
Novartis Ag |
Sposób wytwarzania stałych dyspersji midostauryny
|
AU2007325576B2
(en)
*
|
2006-10-20 |
2013-01-10 |
Icos Corporation |
Compositions of Chk1 inhibitors
|
EP1920785A1
(en)
|
2006-11-07 |
2008-05-14 |
Boehringer Ingelheim Vetmedica Gmbh |
Liquid preparation comprising a complex of pimobendan and cyclodextrin
|
RU2009123536A
(ru)
*
|
2006-11-21 |
2010-12-27 |
Новартис АГ (CH) |
Стабильные парентеральные составы, включающие ингибиторы pcb на основе бензодиазепина
|
MX2010009513A
(es)
*
|
2008-02-28 |
2010-09-22 |
Takeda Pharmaceutical |
Composicion farmaceutica.
|
MX2011005444A
(es)
|
2008-11-25 |
2011-06-09 |
Boehringer Ingelheim Vetmed |
Inhibidores de la fosfodiesterasa tipo iii (pde iii) o agentes sensibilizantes a iones de ca(2+) para el tratamiento de la cardiomiopatia hipertrofica.
|
WO2010088924A1
(en)
|
2009-02-06 |
2010-08-12 |
Telormedix Sa |
Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
|
CN102499909B
(zh)
*
|
2011-12-27 |
2013-08-07 |
哈尔滨三联药业有限公司 |
伊曲康唑分散片及其制备方法
|
KR101383941B1
(ko)
*
|
2012-03-09 |
2014-04-10 |
동아에스티 주식회사 |
피록시캄 또는 약제학적으로 허용되는 그의 염과 히알루론산 또는 약제학적으로 허용되는 그의 염의 안정한 액상 조성물 및 그 제조방법
|
EP2825159B1
(en)
|
2012-03-15 |
2022-06-22 |
Boehringer Ingelheim Vetmedica GmbH |
Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
|
NZ702930A
(en)
*
|
2012-06-28 |
2017-05-26 |
Mcneil-Ppc Inc |
Racecadotril liquid compositions
|
KR102274714B1
(ko)
*
|
2013-03-13 |
2021-07-09 |
씨젠 인크. |
사이클로덱스트린 및 항체-약물 포합체 제형
|
WO2015007760A1
(en)
|
2013-07-19 |
2015-01-22 |
Boehringer Ingelheim Vetmedica Gmbh |
Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
|
EP3054980B1
(en)
*
|
2013-10-08 |
2019-09-04 |
InnoPharma, Inc. |
Aprepitant oral liquid formulations
|
EP3106150B1
(en)
|
2013-12-04 |
2021-07-28 |
Boehringer Ingelheim Vetmedica GmbH |
Improved pharmaceutical compositions of pimobendan
|
US10537570B2
(en)
|
2016-04-06 |
2020-01-21 |
Boehringer Ingelheim Vetmedica Gmbh |
Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
|
CA3068591A1
(en)
*
|
2017-06-30 |
2019-01-03 |
Celgene Corporation |
Compositions and methods of use of 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl) methyl)-2,2-difluoroacetamide
|
US10716774B1
(en)
|
2018-01-05 |
2020-07-21 |
Yale Pharmaceuticals LLC |
Pharmaceutical compositions containing isotretinoin with improved dissolution profile and enhanced stability
|
FR3083234B1
(fr)
*
|
2018-06-29 |
2020-11-27 |
Roquette Freres |
Nouvelles hydroxypropyl-beta-cyclodextrines et leurs procedes de preparation
|
US20210253746A1
(en)
*
|
2018-06-29 |
2021-08-19 |
Roquette Freres |
Novel hydroxypropyl-beta-cyclodextrin and process for the production thereof
|
EP3873604A1
(en)
|
2018-10-29 |
2021-09-08 |
Cycol Therapeutics, Inc. |
Methods for treating alzheimer's disease
|
CN114195733A
(zh)
*
|
2022-01-07 |
2022-03-18 |
华东理工大学 |
一种抑制烯丙苯噻唑异构化的方法
|